Clinical ResearchInfective EndocarditisTemporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications: Three Successive Population-Based Surveys
Key Words
Abbreviation and Acronym
Cited by (0)
This work was supported by the following organizations: L'Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique, Société de Pathologie Infectieuse de Langue Française, Société Française de Microbiologie, Société Nationale Française de Médecine Interne, Société de Réanimation de Langue Française, Société Française de Gérontologie, Société Française de Cardiologie, Société Française de Chirurgie Thoracique et Cardiovasculaire, Société Française d'Anesthésie-Réanimation, Fédération Française de Cardiologie, and the Inserm network on infective endocarditis. This work was supported by a research grant from the French Ministry of Health, the support of the Société Française de Cardiologie, the European Society of Clinical Microbiology and Infectious Diseases, and by Novartis Laboratories. The sponsor was the Département à la Recherche Clinique et à l'innovation (French Ministry of Health), Hôpital Universitaire de Besançon. The sponsor supported the research but had no access to the data. Dr. Iung is a consultant for Boehringer-Ingelheim, Bayer, Valtech, Servier, and Abbott; and has received speaker fees from Edwards Lifesciences and Sanofi-Aventis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.